Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Infinity Pharmaceuticals Inc.

TRADE

NASDAQ: INFIHealthcare / Biotechnology / USA
1.91-0.07-3.54%Vol 370 6841Y Perf 34.75%
Jul 20th, 2018 16:00
BID1.90 ASK1.91
Open1.99 Previous Close1.98
Pre-Market1.99 After-Trading1.94
 0.01 0.51%  0.03 1.57%
Target Price
4.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
135.60 
Finscreener Ranking
★★+     48.68
Insiders Trans % 3/6/12M
71/71/81 
Value Ranking
★★     46.64
Insiders Value % 3/6/12M
99/99/99 
Growth Ranking
★+     42.81
Insiders Shares Cnt. % 3/6/12M
99/99/99 
Income Ranking
 —    -
Market Cap (mil)107 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
34.75 
Earnings Date
2nd Aug 2018

Today's Price Range

1.882.00

 

52wk Range

0.933.75

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
11.05%
3 Months
-14.73%
6 Months
-6.37%
1 Year
34.75%
3 Years
-79.44%
5 Years
-90.27%

Quotes

Name / TickerPriceChg.Chg.%
INFI1.91-0.0700-3.54
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 10.50
Current Ratio 10.80
Long Term Debt to Total Capital 0.21
Total Debt to Equity 0.13
Interest Coverage -50.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-678.80
EBITDA Margin-660.70
Pre-tax Profit Margin-
Profit Margin-19.81
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.52
PS Ratios 19.06
Price to Cash Flow 8.50
Price to Free Cash Flow -6.00
Cash Flow Per Share -0.57
Price to Tangible Book2.52
Book Value per Share0.81
Enterprise Value (in ths.)66 568
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-46.05
ROE last 12 Months -62.40
Return on Assets (5Y Avg) -83.72
ROA last 12 Months -48.05
Return on Capital (5Y Avg) -40.52
ROC last 12 Months -67.13
Return on invested Capital Q -20.10
Return on invested Capital Y-52.43
Assets Turnover0.10
Receivables Turnover123.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)6 000
Revenue per Share 0.11
Revenue Growth 3 Years -66.64
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.18-0.180.00
Q04 2017-0.27-0.1448.15
Q03 2017-0.21-0.1433.33
Q02 2017-0.22-0.34-54.55
Q01 2017-0.22-0.214.55
Q04 2016--0.46-
Q03 2016-0.84-0.3953.57
Q02 2016-0.89-0.4351.69
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.2028.57Positive
9/2018 QR-0.2025.93Positive
12/2018 FY-0.7529.91Positive
12/2019 FY-0.7213.25Positive
Next Report Date2nd Aug 2018
Estimated EPS Next Report-0.20
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume370 684
Shares Outstanding (in ths.)56 070
Trades Count979
Dollar Volume689 801
Avg. Volume654 502
Avg. Weekly Volume191 207
Avg. Monthly Volume474 707
Avg. Quarterly Volume540 142

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

72%28%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.50

There are no comments yet.

News

x